Activity and architecture of pyroglutamate-modified amyloid-β (AβpE3-42) pores

Alan L Gillman1, Hyunbum Jang, Joon Lee

  • 1Department of Bioengineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States.

Insights

Pyroglutamate-modified amyloid-beta (AβpE) peptides form pores in cell membranes, contributing to Alzheimer's disease (AD) toxicity. These AβpE pores exhibit unique structural and functional properties compared to other Aβ pores, offering insights into AD pathogenesis.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Pyroglutamate-modified amyloid-beta (AβpE) peptides are strongly linked to Alzheimer's disease (AD) cytotoxicity.
  • AβpE peptides are the predominant Aβ oligomers in AD brains and accumulate before full-length Aβ plaques.
  • The increased hydrophobicity and resistance to degradation of AβpE contribute to their toxicity, but pore formation activity remains unclear.

Purpose of the Study:

  • To investigate the pore activity of AβpE peptides in anionic lipid membranes.
  • To determine the structural characteristics of AβpE pores using molecular dynamics simulations.
  • To compare the functional and structural properties of AβpE pores with other Aβ pores.

Main Methods:

  • Planar bilayer electrical recording to assess ionic current through AβpE pores.
  • Molecular dynamics simulations to elucidate the structural basis of AβpE pore formation and function.

Main Results:

  • AβpE pores spontaneously induce ionic current across anionic membranes.
  • AβpE pores show delayed onset but increased ion permeability compared to Aβ1-42 pores.
  • The N-termini of AβpE peptides in pores orient towards the lipid core, unlike wild-type Aβ peptides.

Conclusions:

  • AβpE peptides form functional pores in lipid membranes with distinct properties from other Aβ peptides.
  • Structural differences, particularly N-terminal orientation, likely contribute to the enhanced toxicity of AβpE.
  • These findings represent a foundational step in understanding the molecular mechanisms underlying AβpE-associated Alzheimer's disease toxicity.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.1K
Amyloid Fibrils03:03

Amyloid Fibrils

5.2K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K